GLI3
MOLECULAR TARGETGLI family zinc finger 3
GLI3 (GLI family zinc finger 3) is targeted by 194 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting GLI3
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
Showing top 50 of 194 compounds. Use the BiohacksAI search to explore all GLI3 modulators.
About GLI3 as a Drug Target
GLI3 (GLI family zinc finger 3) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 194 compounds with documented GLI3 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
GLI3 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.